To target cellular senescence in diabetic kidney disease: the known and the unknown.
- Published in:
- Clinical Science, 2024, v. 138, n. 16, p. 991, doi. 10.1042/CS20240717
- By:
- Publication type:
- Article
Works matching IS 01435221 AND DT 2024 AND VI 138 AND IP 16
Results: 6
1
2
Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway.
- Published in:
- Clinical Science, 2024, v. 138, n. 16, p. 1025, doi. 10.1042/CS20240302
- By:
- Publication type:
- Article
3
Correction: The complement system in neurodegenerative diseases.
- Published in:
- Clinical Science, 2024, v. 138, n. 16, p. 989, doi. 10.1042/CS-2023-0513C_COR
- Publication type:
- Article
4
Expression of Concern: Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression.
- Published in:
- Clinical Science, 2024, v. 138, n. 16, p. 1023, doi. 10.1042/CS-2007-0250_EOC
- Publication type:
- Article
5
Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions.
- Published in:
- Clinical Science, 2024, v. 138, n. 16, p. 1009, doi. 10.1042/CS20240328
- By:
- Publication type:
- Article
6
Correction: Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma.
- Published in:
- Clinical Science, 2024, v. 138, n. 16, p. 987, doi. 10.1042/CS-2022-0128_COR
- Publication type:
- Article